Detection of HSV Type-2, CMV and Adenovirus lgG Antibodies in Patients with Hematologic and Solid Organ Malignancies
In: European Journal of Therapeutics, Jg. 6 (2023-05-15), S. 131-136
Online
unknown
Zugriff:
The presence of Herpes Simplex Virus-type 2 (HSV type 2), Cytomegalovirus(CMV) and Adenovirus lgG antibodies was determined in sera from a total of 144 patients with hematologic and solid organ malignancies. HSV type-2 antibodies were detected using the EIA method and antibody levels were detected in 34(48.5 %) ofthe hematologic and in 56(75.6 %) ofthe solid organ malignancies with a total of90 (62.5 %). Anti-CMV IgG antibodies were detected in the same serum samples using the complement fixation test. Residual anti-CMV antibody levels were detected in 43(61.4) ofhematologic and 39 (52.7 %) ofsolid organ malignancies with a total of82 (56.9 %) serum samples. Adenovinıs antibodies were detected using the complement fixation test. Residual antibodies were found in 51(72.8 %) of hematologic and in 33(44.5 %) of solid organ malignancies cut of a total of 84(58.3 %).
Titel: |
Detection of HSV Type-2, CMV and Adenovirus lgG Antibodies in Patients with Hematologic and Solid Organ Malignancies
|
---|---|
Autor/in / Beteiligte Person: | Uluhan, Ramazan ; Yaman, Akgün ; İlkit, Macit ; Fatih, KÖKSAL ; Akan, Erol |
Link: | |
Zeitschrift: | European Journal of Therapeutics, Jg. 6 (2023-05-15), S. 131-136 |
Veröffentlichung: | Pera Publishing, 2023 |
Medientyp: | unknown |
ISSN: | 2564-7040 (print) ; 2564-7784 (print) |
DOI: | 10.58600/eurjther.1995-6-2-1521-arch |
Sonstiges: |
|